Navigating Multinational Trials: Trends in Regulatory Risk & ICH E6(R3) Alignment
Master regulatory risk mitigation in multinational trials with actionable steps: assess local frameworks, align with ICH E6(R3), enhance pharmacovigilance, train teams, and leverage patient-focused trial platforms.
Robert Maxwell
Jul 24, 2025
regulatory compliance oncology
pharmacovigilance in cardiology
ICH guidelines stroke research
multinational trial regulations
